483 related articles for article (PubMed ID: 15175242)
1. Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics.
Aslanian A; Iaquinta PJ; Verona R; Lees JA
Genes Dev; 2004 Jun; 18(12):1413-22. PubMed ID: 15175242
[TBL] [Abstract][Full Text] [Related]
2. Regulation of the Arf/p53 tumor surveillance network by E2F.
Iaquinta PJ; Aslanian A; Lees JA
Cold Spring Harb Symp Quant Biol; 2005; 70():309-16. PubMed ID: 16869767
[TBL] [Abstract][Full Text] [Related]
3. ARF directly binds DP1: interaction with DP1 coincides with the G1 arrest function of ARF.
Datta A; Sen J; Hagen J; Korgaonkar CK; Caffrey M; Quelle DE; Hughes DE; Ackerson TJ; Costa RH; Raychaudhuri P
Mol Cell Biol; 2005 Sep; 25(18):8024-36. PubMed ID: 16135794
[TBL] [Abstract][Full Text] [Related]
4. E2F transcriptional repressor complexes are critical downstream targets of p19(ARF)/p53-induced proliferative arrest.
Rowland BD; Denissov SG; Douma S; Stunnenberg HG; Bernards R; Peeper DS
Cancer Cell; 2002 Jul; 2(1):55-65. PubMed ID: 12150825
[TBL] [Abstract][Full Text] [Related]
5. The inhibitor of cyclin-dependent kinase 4a/alternative reading frame (INK4a/ARF) locus encoded proteins p16INK4a and p19ARF repress cyclin D1 transcription through distinct cis elements.
D'Amico M; Wu K; Fu M; Rao M; Albanese C; Russell RG; Lian H; Bregman D; White MA; Pestell RG
Cancer Res; 2004 Jun; 64(12):4122-30. PubMed ID: 15205322
[TBL] [Abstract][Full Text] [Related]
6. Activation of ARF by oncogenic stress in mouse fibroblasts is independent of E2F1 and E2F2.
Palmero I; Murga M; Zubiaga A; Serrano M
Oncogene; 2002 May; 21(19):2939-47. PubMed ID: 12082524
[TBL] [Abstract][Full Text] [Related]
7. p19(ARF) is dispensable for oncogenic stress-induced p53-mediated apoptosis and tumor suppression in vivo.
Tolbert D; Lu X; Yin C; Tantama M; Van Dyke T
Mol Cell Biol; 2002 Jan; 22(1):370-7. PubMed ID: 11739748
[TBL] [Abstract][Full Text] [Related]
8. Transcriptional regulation of the human tumor suppressor p14(ARF) by E2F1, E2F2, E2F3, and Sp1-like factors.
Parisi T; Pollice A; Di Cristofano A; Calabrò V; La Mantia G
Biochem Biophys Res Commun; 2002 Mar; 291(5):1138-45. PubMed ID: 11883935
[TBL] [Abstract][Full Text] [Related]
9. Loss of p19(ARF) eliminates the requirement for the pRB-binding motif in simian virus 40 large T antigen-mediated transformation.
Chao HH; Buchmann AM; DeCaprio JA
Mol Cell Biol; 2000 Oct; 20(20):7624-33. PubMed ID: 11003658
[TBL] [Abstract][Full Text] [Related]
10. The differential impact of p16(INK4a) or p19(ARF) deficiency on cell growth and tumorigenesis.
Sharpless NE; Ramsey MR; Balasubramanian P; Castrillon DH; DePinho RA
Oncogene; 2004 Jan; 23(2):379-85. PubMed ID: 14724566
[TBL] [Abstract][Full Text] [Related]
11. Resistance of primary cultured mouse hepatic tumor cells to cellular senescence despite expression of p16(Ink4a), p19(Arf), p53, and p21(Waf1/Cip1).
Obata M; Imamura E; Yoshida Y; Goto J; Kishibe K; Yasuda A; Ogawa K
Mol Carcinog; 2001 Sep; 32(1):9-18. PubMed ID: 11568971
[TBL] [Abstract][Full Text] [Related]
12. E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity.
Danielian PS; Friesenhahn LB; Faust AM; West JC; Caron AM; Bronson RT; Lees JA
Oncogene; 2008 Nov; 27(51):6561-70. PubMed ID: 18663357
[TBL] [Abstract][Full Text] [Related]
13. C/EBPbeta cooperates with RB:E2F to implement Ras(V12)-induced cellular senescence.
Sebastian T; Malik R; Thomas S; Sage J; Johnson PF
EMBO J; 2005 Sep; 24(18):3301-12. PubMed ID: 16107878
[TBL] [Abstract][Full Text] [Related]
14. Cdk4 disruption renders primary mouse cells resistant to oncogenic transformation, leading to Arf/p53-independent senescence.
Zou X; Ray D; Aziyu A; Christov K; Boiko AD; Gudkov AV; Kiyokawa H
Genes Dev; 2002 Nov; 16(22):2923-34. PubMed ID: 12435633
[TBL] [Abstract][Full Text] [Related]
15. E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop.
Timmers C; Sharma N; Opavsky R; Maiti B; Wu L; Wu J; Orringer D; Trikha P; Saavedra HI; Leone G
Mol Cell Biol; 2007 Jan; 27(1):65-78. PubMed ID: 17167174
[TBL] [Abstract][Full Text] [Related]
16. Polycomb complexes regulate cellular senescence by repression of ARF in cooperation with E2F3.
Miki J; Fujimura Y; Koseki H; Kamijo T
Genes Cells; 2007 Dec; 12(12):1371-82. PubMed ID: 18076574
[TBL] [Abstract][Full Text] [Related]
17. E2F activity is essential for survival of Myc-overexpressing human cancer cells.
Santoni-Rugiu E; Duro D; Farkas T; Mathiasen IS; Jäättelä M; Bartek J; Lukas J
Oncogene; 2002 Sep; 21(42):6498-509. PubMed ID: 12226753
[TBL] [Abstract][Full Text] [Related]
18. E2F3-a novel repressor of the ARF/p53 pathway.
Ginsberg D
Dev Cell; 2004 Jun; 6(6):742-3. PubMed ID: 15177020
[TBL] [Abstract][Full Text] [Related]
19. Bcl-2 is an apoptotic target suppressed by both c-Myc and E2F-1.
Eischen CM; Packham G; Nip J; Fee BE; Hiebert SW; Zambetti GP; Cleveland JL
Oncogene; 2001 Oct; 20(48):6983-93. PubMed ID: 11704823
[TBL] [Abstract][Full Text] [Related]
20. p53-Dependent and -independent functions of the Arf tumor suppressor.
Sherr CJ; Bertwistle D; DEN Besten W; Kuo ML; Sugimoto M; Tago K; Williams RT; Zindy F; Roussel MF
Cold Spring Harb Symp Quant Biol; 2005; 70():129-37. PubMed ID: 16869746
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]